Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Human UDP-Glucuronosyltransferase (UGT) 2B10 in Drug N-Glucuronidation: Substrate Screening and Comparison with UGT1A3 and UGT1A4

Yukiko Kato, Takeshi Izukawa, Shingo Oda, Tatsuki Fukami, Moshe Finel, Tsuyoshi Yokoi and Miki Nakajima
Drug Metabolism and Disposition July 2013, 41 (7) 1389-1397; DOI: https://doi.org/10.1124/dmd.113.051565
Yukiko Kato
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Izukawa
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shingo Oda
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatsuki Fukami
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moshe Finel
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuyoshi Yokoi
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miki Nakajima
Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 41 no. 7 1389-1397
DOI 
https://doi.org/10.1124/dmd.113.051565
PubMed 
23611809

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 13, 2013
  • Accepted April 23, 2013
  • Published online June 13, 2013.

Article Versions

  • Earlier version (April 23, 2013 - 08:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yukiko Kato,
  2. Takeshi Izukawa,
  3. Shingo Oda,
  4. Tatsuki Fukami,
  5. Moshe Finel,
  6. Tsuyoshi Yokoi, and
  7. Miki Nakajima
  1. Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan (Y.K., T.I., S.O., T.F., T.Y., M.N.); and Center for Drug Research and Division of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland (M.F.)
  1. Address correspondence to:
    Dr. Miki Nakajima, Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan. E-mail: nmiki{at}p.kanazawa-u.ac.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to December 2023

AbstractFullPdf
Aug 201752525
Sep 201704522
Oct 201704031
Nov 201732116
Dec 201772717
Jan 201844116
Feb 201812818
Mar 201823415
Apr 201833524
May 201842422
Jun 201802515
Jul 20181159
Aug 201832419
Sep 201824519
Oct 201853415
Nov 201812610
Dec 201814118
Jan 201916711
Feb 20191747
Mar 2019171014
Apr 201932520
May 201930610
Jun 201912611
Jul 201929610
Aug 2019321015
Oct 201931514
Nov 2019531515
Dec 20194276
Jan 202043127
Feb 202026158
Mar 20203199
May 20201346
Jun 202091310
Jul 20203423
Aug 202045313
Sep 2020151312
Oct 202039308
Nov 20202297
Dec 20201653
Jan 202129169
Feb 202133189
Mar 202134176
Apr 20213263
May 20215595
Jun 2021192311
Jul 202118135
Aug 202132166
Sep 2021281911
Oct 202124112
Nov 20214146
Dec 20213356
Jan 20222357
Feb 20222420
Mar 20222933
Apr 202227118
May 20223556
Jun 20222851
Jul 2022381020
Aug 20221736
Sep 202235172
Oct 202218135
Nov 20221778
Dec 20222524
Jan 20234041
Feb 20231247
Mar 20232596
Apr 202319311
May 202335176
Jun 20231473
Jul 20232456
Aug 20232191
Sep 202328514
Oct 202321810
Nov 20232645
Dec 2023822

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 41 (7)
Drug Metabolism and Disposition
Vol. 41, Issue 7
1 Jul 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human UDP-Glucuronosyltransferase (UGT) 2B10 in Drug N-Glucuronidation: Substrate Screening and Comparison with UGT1A3 and UGT1A4
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Significance of UGT2B10 in N-Glucuronidation of Drugs

Yukiko Kato, Takeshi Izukawa, Shingo Oda, Tatsuki Fukami, Moshe Finel, Tsuyoshi Yokoi and Miki Nakajima
Drug Metabolism and Disposition July 1, 2013, 41 (7) 1389-1397; DOI: https://doi.org/10.1124/dmd.113.051565

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Significance of UGT2B10 in N-Glucuronidation of Drugs

Yukiko Kato, Takeshi Izukawa, Shingo Oda, Tatsuki Fukami, Moshe Finel, Tsuyoshi Yokoi and Miki Nakajima
Drug Metabolism and Disposition July 1, 2013, 41 (7) 1389-1397; DOI: https://doi.org/10.1124/dmd.113.051565
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Metabolism of HSK3486 in humans
  • A MDCKII-MDR1-BCRP cell line to assess efflux at the BBB
  • Influence of CYP3A5 on vincristine disposition and toxicity
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics